ArticleNeurology. Genetics2022
A Remote Longitudinal Observational Study of Individuals at Genetic Risk for Parkinson Disease: Baseline Results.
Abstract read
In one paragraph
Article in Neurology. Genetics, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.
0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
–field-weighted citation impact
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
11 citing papers in PubMed.
- Multimodal Remote Digital Phenotyping for Detecting and Tracking Early Parkinsonian Change in LRRK2 Carriers.Research square · 2026Article
- Validation of remote multimodal AI screening for Parkinson disease across diverse settings.Communications medicine · 2026Article
- Prediction of α-synuclein seed amplification assay positivity in remotely followedJournal of clinical and translational science · 2026Article
- How Well Do Essential Tremor Patients Report whether or Not They Have Parkinson's Disease? Validity of Self-Report Data from a Large Cohort Study.Neuroepidemiology · 2026Article
- Locally adapting digital health technologies to address the global challenge of Parkinson's disease.Equity neuroscience · 2025Article
- Stable two-year longitudinal clinical outcomes in LRRK2 G2019S non-manifest carriers in a remote nationwide study.Parkinsonism & related disorders · 2025Article
- Genetic analysis and natural history of Parkinson's disease due to the LRRK2 G2019S variant.Brain : a journal of neurology · 2024Article
- Best Practices and Recommendations for Research Using Virtual Real-Time Data Collection: Protocol for Virtual Data Collection Studies.JMIR research protocols · 2024Article
- Return of individual research results to participants with and at risk for Parkinson's disease.Journal of clinical and translational science · 2024Article
- Conversion Rate of Essential Tremor to Essential Tremor Parkinson Disease: Data From a Prospective Longitudinal Study.Neurology. Clinical practice · 2023Article
- Proposal for a Biologic Staging System of Parkinson's Disease.Journal of Parkinson's disease · 2023Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
24 authors.
Stella Jensen-RobertsCenter for Health + Technology (S.J.-R., T.L.M., P.A., J.S., M.P., S.S., R.W., A.S., M.P.M., D.K., E.F.A., R.G.H., E.R.D., R.B.S.), University of Rochester Medical Center, NY; Department of Brain and Psychological Sciences (T.L.M.), Boston University, MA; Department of Neurology (P.A., B.V., M.P.M., K.B., D.K., E.F.A., R.G.H., E.R.D., R.B.S.), University of Rochester Medical Center, NY; 23andMe, Inc. (P.C., H.M.R., D.C., E.C.), Sunnyvale, CA; Department of Neurology (K.A.), Westchester Medical Center, Poughkeepsie, NY; USA Department of Biostatistics and Computational Biology (M.P.M.), University of Rochester Medical Center, NY; Department of Neurology (R.N.A.), Columbia University, New York; Eli Lilly and Company (K.B.), Indianapolis, IN; Weill Institute for Neurosciences (C.T.), University of California, San Francisco; Valley Oaks Health (R.W.-E.), Lafayette, IN; and Department of Neurology and Neurogenetics (E.F.A.), Kennedy Krieger Institute, Baltimore, MD.
Taylor L MyersCenter for Health + Technology (S.J.-R., T.L.M., P.A., J.S., M.P., S.S., R.W., A.S., M.P.M., D.K., E.F.A., R.G.H., E.R.D., R.B.S.), University of Rochester Medical Center, NY; Department of Brain and Psychological Sciences (T.L.M.), Boston University, MA; Department of Neurology (P.A., B.V., M.P.M., K.B., D.K., E.F.A., R.G.H., E.R.D., R.B.S.), University of Rochester Medical Center, NY; 23andMe, Inc. (P.C., H.M.R., D.C., E.C.), Sunnyvale, CA; Department of Neurology (K.A.), Westchester Medical Center, Poughkeepsie, NY; USA Department of Biostatistics and Computational Biology (M.P.M.), University of Rochester Medical Center, NY; Department of Neurology (R.N.A.), Columbia University, New York; Eli Lilly and Company (K.B.), Indianapolis, IN; Weill Institute for Neurosciences (C.T.), University of California, San Francisco; Valley Oaks Health (R.W.-E.), Lafayette, IN; and Department of Neurology and Neurogenetics (E.F.A.), Kennedy Krieger Institute, Baltimore, MD.
Peggy AuingerCenter for Health + Technology (S.J.-R., T.L.M., P.A., J.S., M.P., S.S., R.W., A.S., M.P.M., D.K., E.F.A., R.G.H., E.R.D., R.B.S.), University of Rochester Medical Center, NY; Department of Brain and Psychological Sciences (T.L.M.), Boston University, MA; Department of Neurology (P.A., B.V., M.P.M., K.B., D.K., E.F.A., R.G.H., E.R.D., R.B.S.), University of Rochester Medical Center, NY; 23andMe, Inc. (P.C., H.M.R., D.C., E.C.), Sunnyvale, CA; Department of Neurology (K.A.), Westchester Medical Center, Poughkeepsie, NY; USA Department of Biostatistics and Computational Biology (M.P.M.), University of Rochester Medical Center, NY; Department of Neurology (R.N.A.), Columbia University, New York; Eli Lilly and Company (K.B.), Indianapolis, IN; Weill Institute for Neurosciences (C.T.), University of California, San Francisco; Valley Oaks Health (R.W.-E.), Lafayette, IN; and Department of Neurology and Neurogenetics (E.F.A.), Kennedy Krieger Institute, Baltimore, MD.
Paul CannonCenter for Health + Technology (S.J.-R., T.L.M., P.A., J.S., M.P., S.S., R.W., A.S., M.P.M., D.K., E.F.A., R.G.H., E.R.D., R.B.S.), University of Rochester Medical Center, NY; Department of Brain and Psychological Sciences (T.L.M.), Boston University, MA; Department of Neurology (P.A., B.V., M.P.M., K.B., D.K., E.F.A., R.G.H., E.R.D., R.B.S.), University of Rochester Medical Center, NY; 23andMe, Inc. (P.C., H.M.R., D.C., E.C.), Sunnyvale, CA; Department of Neurology (K.A.), Westchester Medical Center, Poughkeepsie, NY; USA Department of Biostatistics and Computational Biology (M.P.M.), University of Rochester Medical Center, NY; Department of Neurology (R.N.A.), Columbia University, New York; Eli Lilly and Company (K.B.), Indianapolis, IN; Weill Institute for Neurosciences (C.T.), University of California, San Francisco; Valley Oaks Health (R.W.-E.), Lafayette, IN; and Department of Neurology and Neurogenetics (E.F.A.), Kennedy Krieger Institute, Baltimore, MD.
Helen M RowbothamCenter for Health + Technology (S.J.-R., T.L.M., P.A., J.S., M.P., S.S., R.W., A.S., M.P.M., D.K., E.F.A., R.G.H., E.R.D., R.B.S.), University of Rochester Medical Center, NY; Department of Brain and Psychological Sciences (T.L.M.), Boston University, MA; Department of Neurology (P.A., B.V., M.P.M., K.B., D.K., E.F.A., R.G.H., E.R.D., R.B.S.), University of Rochester Medical Center, NY; 23andMe, Inc. (P.C., H.M.R., D.C., E.C.), Sunnyvale, CA; Department of Neurology (K.A.), Westchester Medical Center, Poughkeepsie, NY; USA Department of Biostatistics and Computational Biology (M.P.M.), University of Rochester Medical Center, NY; Department of Neurology (R.N.A.), Columbia University, New York; Eli Lilly and Company (K.B.), Indianapolis, IN; Weill Institute for Neurosciences (C.T.), University of California, San Francisco; Valley Oaks Health (R.W.-E.), Lafayette, IN; and Department of Neurology and Neurogenetics (E.F.A.), Kennedy Krieger Institute, Baltimore, MD.
Daniella CokerCenter for Health + Technology (S.J.-R., T.L.M., P.A., J.S., M.P., S.S., R.W., A.S., M.P.M., D.K., E.F.A., R.G.H., E.R.D., R.B.S.), University of Rochester Medical Center, NY; Department of Brain and Psychological Sciences (T.L.M.), Boston University, MA; Department of Neurology (P.A., B.V., M.P.M., K.B., D.K., E.F.A., R.G.H., E.R.D., R.B.S.), University of Rochester Medical Center, NY; 23andMe, Inc. (P.C., H.M.R., D.C., E.C.), Sunnyvale, CA; Department of Neurology (K.A.), Westchester Medical Center, Poughkeepsie, NY; USA Department of Biostatistics and Computational Biology (M.P.M.), University of Rochester Medical Center, NY; Department of Neurology (R.N.A.), Columbia University, New York; Eli Lilly and Company (K.B.), Indianapolis, IN; Weill Institute for Neurosciences (C.T.), University of California, San Francisco; Valley Oaks Health (R.W.-E.), Lafayette, IN; and Department of Neurology and Neurogenetics (E.F.A.), Kennedy Krieger Institute, Baltimore, MD.ORCID https://orcid.org/0000-0003-3780-067X
Eli ChanoffCenter for Health + Technology (S.J.-R., T.L.M., P.A., J.S., M.P., S.S., R.W., A.S., M.P.M., D.K., E.F.A., R.G.H., E.R.D., R.B.S.), University of Rochester Medical Center, NY; Department of Brain and Psychological Sciences (T.L.M.), Boston University, MA; Department of Neurology (P.A., B.V., M.P.M., K.B., D.K., E.F.A., R.G.H., E.R.D., R.B.S.), University of Rochester Medical Center, NY; 23andMe, Inc. (P.C., H.M.R., D.C., E.C.), Sunnyvale, CA; Department of Neurology (K.A.), Westchester Medical Center, Poughkeepsie, NY; USA Department of Biostatistics and Computational Biology (M.P.M.), University of Rochester Medical Center, NY; Department of Neurology (R.N.A.), Columbia University, New York; Eli Lilly and Company (K.B.), Indianapolis, IN; Weill Institute for Neurosciences (C.T.), University of California, San Francisco; Valley Oaks Health (R.W.-E.), Lafayette, IN; and Department of Neurology and Neurogenetics (E.F.A.), Kennedy Krieger Institute, Baltimore, MD.
Julia SotoCenter for Health + Technology (S.J.-R., T.L.M., P.A., J.S., M.P., S.S., R.W., A.S., M.P.M., D.K., E.F.A., R.G.H., E.R.D., R.B.S.), University of Rochester Medical Center, NY; Department of Brain and Psychological Sciences (T.L.M.), Boston University, MA; Department of Neurology (P.A., B.V., M.P.M., K.B., D.K., E.F.A., R.G.H., E.R.D., R.B.S.), University of Rochester Medical Center, NY; 23andMe, Inc. (P.C., H.M.R., D.C., E.C.), Sunnyvale, CA; Department of Neurology (K.A.), Westchester Medical Center, Poughkeepsie, NY; USA Department of Biostatistics and Computational Biology (M.P.M.), University of Rochester Medical Center, NY; Department of Neurology (R.N.A.), Columbia University, New York; Eli Lilly and Company (K.B.), Indianapolis, IN; Weill Institute for Neurosciences (C.T.), University of California, San Francisco; Valley Oaks Health (R.W.-E.), Lafayette, IN; and Department of Neurology and Neurogenetics (E.F.A.), Kennedy Krieger Institute, Baltimore, MD.
Meghan PawlikCenter for Health + Technology (S.J.-R., T.L.M., P.A., J.S., M.P., S.S., R.W., A.S., M.P.M., D.K., E.F.A., R.G.H., E.R.D., R.B.S.), University of Rochester Medical Center, NY; Department of Brain and Psychological Sciences (T.L.M.), Boston University, MA; Department of Neurology (P.A., B.V., M.P.M., K.B., D.K., E.F.A., R.G.H., E.R.D., R.B.S.), University of Rochester Medical Center, NY; 23andMe, Inc. (P.C., H.M.R., D.C., E.C.), Sunnyvale, CA; Department of Neurology (K.A.), Westchester Medical Center, Poughkeepsie, NY; USA Department of Biostatistics and Computational Biology (M.P.M.), University of Rochester Medical Center, NY; Department of Neurology (R.N.A.), Columbia University, New York; Eli Lilly and Company (K.B.), Indianapolis, IN; Weill Institute for Neurosciences (C.T.), University of California, San Francisco; Valley Oaks Health (R.W.-E.), Lafayette, IN; and Department of Neurology and Neurogenetics (E.F.A.), Kennedy Krieger Institute, Baltimore, MD.ORCID https://orcid.org/0000-0002-9025-0382
Katherine AmodeoCenter for Health + Technology (S.J.-R., T.L.M., P.A., J.S., M.P., S.S., R.W., A.S., M.P.M., D.K., E.F.A., R.G.H., E.R.D., R.B.S.), University of Rochester Medical Center, NY; Department of Brain and Psychological Sciences (T.L.M.), Boston University, MA; Department of Neurology (P.A., B.V., M.P.M., K.B., D.K., E.F.A., R.G.H., E.R.D., R.B.S.), University of Rochester Medical Center, NY; 23andMe, Inc. (P.C., H.M.R., D.C., E.C.), Sunnyvale, CA; Department of Neurology (K.A.), Westchester Medical Center, Poughkeepsie, NY; USA Department of Biostatistics and Computational Biology (M.P.M.), University of Rochester Medical Center, NY; Department of Neurology (R.N.A.), Columbia University, New York; Eli Lilly and Company (K.B.), Indianapolis, IN; Weill Institute for Neurosciences (C.T.), University of California, San Francisco; Valley Oaks Health (R.W.-E.), Lafayette, IN; and Department of Neurology and Neurogenetics (E.F.A.), Kennedy Krieger Institute, Baltimore, MD.
Saloni SharmaCenter for Health + Technology (S.J.-R., T.L.M., P.A., J.S., M.P., S.S., R.W., A.S., M.P.M., D.K., E.F.A., R.G.H., E.R.D., R.B.S.), University of Rochester Medical Center, NY; Department of Brain and Psychological Sciences (T.L.M.), Boston University, MA; Department of Neurology (P.A., B.V., M.P.M., K.B., D.K., E.F.A., R.G.H., E.R.D., R.B.S.), University of Rochester Medical Center, NY; 23andMe, Inc. (P.C., H.M.R., D.C., E.C.), Sunnyvale, CA; Department of Neurology (K.A.), Westchester Medical Center, Poughkeepsie, NY; USA Department of Biostatistics and Computational Biology (M.P.M.), University of Rochester Medical Center, NY; Department of Neurology (R.N.A.), Columbia University, New York; Eli Lilly and Company (K.B.), Indianapolis, IN; Weill Institute for Neurosciences (C.T.), University of California, San Francisco; Valley Oaks Health (R.W.-E.), Lafayette, IN; and Department of Neurology and Neurogenetics (E.F.A.), Kennedy Krieger Institute, Baltimore, MD.
Blanca ValdovinosCenter for Health + Technology (S.J.-R., T.L.M., P.A., J.S., M.P., S.S., R.W., A.S., M.P.M., D.K., E.F.A., R.G.H., E.R.D., R.B.S.), University of Rochester Medical Center, NY; Department of Brain and Psychological Sciences (T.L.M.), Boston University, MA; Department of Neurology (P.A., B.V., M.P.M., K.B., D.K., E.F.A., R.G.H., E.R.D., R.B.S.), University of Rochester Medical Center, NY; 23andMe, Inc. (P.C., H.M.R., D.C., E.C.), Sunnyvale, CA; Department of Neurology (K.A.), Westchester Medical Center, Poughkeepsie, NY; USA Department of Biostatistics and Computational Biology (M.P.M.), University of Rochester Medical Center, NY; Department of Neurology (R.N.A.), Columbia University, New York; Eli Lilly and Company (K.B.), Indianapolis, IN; Weill Institute for Neurosciences (C.T.), University of California, San Francisco; Valley Oaks Health (R.W.-E.), Lafayette, IN; and Department of Neurology and Neurogenetics (E.F.A.), Kennedy Krieger Institute, Baltimore, MD.
Renee WilsonCenter for Health + Technology (S.J.-R., T.L.M., P.A., J.S., M.P., S.S., R.W., A.S., M.P.M., D.K., E.F.A., R.G.H., E.R.D., R.B.S.), University of Rochester Medical Center, NY; Department of Brain and Psychological Sciences (T.L.M.), Boston University, MA; Department of Neurology (P.A., B.V., M.P.M., K.B., D.K., E.F.A., R.G.H., E.R.D., R.B.S.), University of Rochester Medical Center, NY; 23andMe, Inc. (P.C., H.M.R., D.C., E.C.), Sunnyvale, CA; Department of Neurology (K.A.), Westchester Medical Center, Poughkeepsie, NY; USA Department of Biostatistics and Computational Biology (M.P.M.), University of Rochester Medical Center, NY; Department of Neurology (R.N.A.), Columbia University, New York; Eli Lilly and Company (K.B.), Indianapolis, IN; Weill Institute for Neurosciences (C.T.), University of California, San Francisco; Valley Oaks Health (R.W.-E.), Lafayette, IN; and Department of Neurology and Neurogenetics (E.F.A.), Kennedy Krieger Institute, Baltimore, MD.
Aayush SarkarCenter for Health + Technology (S.J.-R., T.L.M., P.A., J.S., M.P., S.S., R.W., A.S., M.P.M., D.K., E.F.A., R.G.H., E.R.D., R.B.S.), University of Rochester Medical Center, NY; Department of Brain and Psychological Sciences (T.L.M.), Boston University, MA; Department of Neurology (P.A., B.V., M.P.M., K.B., D.K., E.F.A., R.G.H., E.R.D., R.B.S.), University of Rochester Medical Center, NY; 23andMe, Inc. (P.C., H.M.R., D.C., E.C.), Sunnyvale, CA; Department of Neurology (K.A.), Westchester Medical Center, Poughkeepsie, NY; USA Department of Biostatistics and Computational Biology (M.P.M.), University of Rochester Medical Center, NY; Department of Neurology (R.N.A.), Columbia University, New York; Eli Lilly and Company (K.B.), Indianapolis, IN; Weill Institute for Neurosciences (C.T.), University of California, San Francisco; Valley Oaks Health (R.W.-E.), Lafayette, IN; and Department of Neurology and Neurogenetics (E.F.A.), Kennedy Krieger Institute, Baltimore, MD.
Michael P McDermottCenter for Health + Technology (S.J.-R., T.L.M., P.A., J.S., M.P., S.S., R.W., A.S., M.P.M., D.K., E.F.A., R.G.H., E.R.D., R.B.S.), University of Rochester Medical Center, NY; Department of Brain and Psychological Sciences (T.L.M.), Boston University, MA; Department of Neurology (P.A., B.V., M.P.M., K.B., D.K., E.F.A., R.G.H., E.R.D., R.B.S.), University of Rochester Medical Center, NY; 23andMe, Inc. (P.C., H.M.R., D.C., E.C.), Sunnyvale, CA; Department of Neurology (K.A.), Westchester Medical Center, Poughkeepsie, NY; USA Department of Biostatistics and Computational Biology (M.P.M.), University of Rochester Medical Center, NY; Department of Neurology (R.N.A.), Columbia University, New York; Eli Lilly and Company (K.B.), Indianapolis, IN; Weill Institute for Neurosciences (C.T.), University of California, San Francisco; Valley Oaks Health (R.W.-E.), Lafayette, IN; and Department of Neurology and Neurogenetics (E.F.A.), Kennedy Krieger Institute, Baltimore, MD.
Roy N AlcalayCenter for Health + Technology (S.J.-R., T.L.M., P.A., J.S., M.P., S.S., R.W., A.S., M.P.M., D.K., E.F.A., R.G.H., E.R.D., R.B.S.), University of Rochester Medical Center, NY; Department of Brain and Psychological Sciences (T.L.M.), Boston University, MA; Department of Neurology (P.A., B.V., M.P.M., K.B., D.K., E.F.A., R.G.H., E.R.D., R.B.S.), University of Rochester Medical Center, NY; 23andMe, Inc. (P.C., H.M.R., D.C., E.C.), Sunnyvale, CA; Department of Neurology (K.A.), Westchester Medical Center, Poughkeepsie, NY; USA Department of Biostatistics and Computational Biology (M.P.M.), University of Rochester Medical Center, NY; Department of Neurology (R.N.A.), Columbia University, New York; Eli Lilly and Company (K.B.), Indianapolis, IN; Weill Institute for Neurosciences (C.T.), University of California, San Francisco; Valley Oaks Health (R.W.-E.), Lafayette, IN; and Department of Neurology and Neurogenetics (E.F.A.), Kennedy Krieger Institute, Baltimore, MD.ORCID https://orcid.org/0000-0002-5717-4875
Kevin BiglanCenter for Health + Technology (S.J.-R., T.L.M., P.A., J.S., M.P., S.S., R.W., A.S., M.P.M., D.K., E.F.A., R.G.H., E.R.D., R.B.S.), University of Rochester Medical Center, NY; Department of Brain and Psychological Sciences (T.L.M.), Boston University, MA; Department of Neurology (P.A., B.V., M.P.M., K.B., D.K., E.F.A., R.G.H., E.R.D., R.B.S.), University of Rochester Medical Center, NY; 23andMe, Inc. (P.C., H.M.R., D.C., E.C.), Sunnyvale, CA; Department of Neurology (K.A.), Westchester Medical Center, Poughkeepsie, NY; USA Department of Biostatistics and Computational Biology (M.P.M.), University of Rochester Medical Center, NY; Department of Neurology (R.N.A.), Columbia University, New York; Eli Lilly and Company (K.B.), Indianapolis, IN; Weill Institute for Neurosciences (C.T.), University of California, San Francisco; Valley Oaks Health (R.W.-E.), Lafayette, IN; and Department of Neurology and Neurogenetics (E.F.A.), Kennedy Krieger Institute, Baltimore, MD.
Daniel KinelCenter for Health + Technology (S.J.-R., T.L.M., P.A., J.S., M.P., S.S., R.W., A.S., M.P.M., D.K., E.F.A., R.G.H., E.R.D., R.B.S.), University of Rochester Medical Center, NY; Department of Brain and Psychological Sciences (T.L.M.), Boston University, MA; Department of Neurology (P.A., B.V., M.P.M., K.B., D.K., E.F.A., R.G.H., E.R.D., R.B.S.), University of Rochester Medical Center, NY; 23andMe, Inc. (P.C., H.M.R., D.C., E.C.), Sunnyvale, CA; Department of Neurology (K.A.), Westchester Medical Center, Poughkeepsie, NY; USA Department of Biostatistics and Computational Biology (M.P.M.), University of Rochester Medical Center, NY; Department of Neurology (R.N.A.), Columbia University, New York; Eli Lilly and Company (K.B.), Indianapolis, IN; Weill Institute for Neurosciences (C.T.), University of California, San Francisco; Valley Oaks Health (R.W.-E.), Lafayette, IN; and Department of Neurology and Neurogenetics (E.F.A.), Kennedy Krieger Institute, Baltimore, MD.
Caroline TannerCenter for Health + Technology (S.J.-R., T.L.M., P.A., J.S., M.P., S.S., R.W., A.S., M.P.M., D.K., E.F.A., R.G.H., E.R.D., R.B.S.), University of Rochester Medical Center, NY; Department of Brain and Psychological Sciences (T.L.M.), Boston University, MA; Department of Neurology (P.A., B.V., M.P.M., K.B., D.K., E.F.A., R.G.H., E.R.D., R.B.S.), University of Rochester Medical Center, NY; 23andMe, Inc. (P.C., H.M.R., D.C., E.C.), Sunnyvale, CA; Department of Neurology (K.A.), Westchester Medical Center, Poughkeepsie, NY; USA Department of Biostatistics and Computational Biology (M.P.M.), University of Rochester Medical Center, NY; Department of Neurology (R.N.A.), Columbia University, New York; Eli Lilly and Company (K.B.), Indianapolis, IN; Weill Institute for Neurosciences (C.T.), University of California, San Francisco; Valley Oaks Health (R.W.-E.), Lafayette, IN; and Department of Neurology and Neurogenetics (E.F.A.), Kennedy Krieger Institute, Baltimore, MD.
Reni Winter-EvansCenter for Health + Technology (S.J.-R., T.L.M., P.A., J.S., M.P., S.S., R.W., A.S., M.P.M., D.K., E.F.A., R.G.H., E.R.D., R.B.S.), University of Rochester Medical Center, NY; Department of Brain and Psychological Sciences (T.L.M.), Boston University, MA; Department of Neurology (P.A., B.V., M.P.M., K.B., D.K., E.F.A., R.G.H., E.R.D., R.B.S.), University of Rochester Medical Center, NY; 23andMe, Inc. (P.C., H.M.R., D.C., E.C.), Sunnyvale, CA; Department of Neurology (K.A.), Westchester Medical Center, Poughkeepsie, NY; USA Department of Biostatistics and Computational Biology (M.P.M.), University of Rochester Medical Center, NY; Department of Neurology (R.N.A.), Columbia University, New York; Eli Lilly and Company (K.B.), Indianapolis, IN; Weill Institute for Neurosciences (C.T.), University of California, San Francisco; Valley Oaks Health (R.W.-E.), Lafayette, IN; and Department of Neurology and Neurogenetics (E.F.A.), Kennedy Krieger Institute, Baltimore, MD.
Erika F AugustineCenter for Health + Technology (S.J.-R., T.L.M., P.A., J.S., M.P., S.S., R.W., A.S., M.P.M., D.K., E.F.A., R.G.H., E.R.D., R.B.S.), University of Rochester Medical Center, NY; Department of Brain and Psychological Sciences (T.L.M.), Boston University, MA; Department of Neurology (P.A., B.V., M.P.M., K.B., D.K., E.F.A., R.G.H., E.R.D., R.B.S.), University of Rochester Medical Center, NY; 23andMe, Inc. (P.C., H.M.R., D.C., E.C.), Sunnyvale, CA; Department of Neurology (K.A.), Westchester Medical Center, Poughkeepsie, NY; USA Department of Biostatistics and Computational Biology (M.P.M.), University of Rochester Medical Center, NY; Department of Neurology (R.N.A.), Columbia University, New York; Eli Lilly and Company (K.B.), Indianapolis, IN; Weill Institute for Neurosciences (C.T.), University of California, San Francisco; Valley Oaks Health (R.W.-E.), Lafayette, IN; and Department of Neurology and Neurogenetics (E.F.A.), Kennedy Krieger Institute, Baltimore, MD.
Robert G HollowayCenter for Health + Technology (S.J.-R., T.L.M., P.A., J.S., M.P., S.S., R.W., A.S., M.P.M., D.K., E.F.A., R.G.H., E.R.D., R.B.S.), University of Rochester Medical Center, NY; Department of Brain and Psychological Sciences (T.L.M.), Boston University, MA; Department of Neurology (P.A., B.V., M.P.M., K.B., D.K., E.F.A., R.G.H., E.R.D., R.B.S.), University of Rochester Medical Center, NY; 23andMe, Inc. (P.C., H.M.R., D.C., E.C.), Sunnyvale, CA; Department of Neurology (K.A.), Westchester Medical Center, Poughkeepsie, NY; USA Department of Biostatistics and Computational Biology (M.P.M.), University of Rochester Medical Center, NY; Department of Neurology (R.N.A.), Columbia University, New York; Eli Lilly and Company (K.B.), Indianapolis, IN; Weill Institute for Neurosciences (C.T.), University of California, San Francisco; Valley Oaks Health (R.W.-E.), Lafayette, IN; and Department of Neurology and Neurogenetics (E.F.A.), Kennedy Krieger Institute, Baltimore, MD.
E Ray DorseyCenter for Health + Technology (S.J.-R., T.L.M., P.A., J.S., M.P., S.S., R.W., A.S., M.P.M., D.K., E.F.A., R.G.H., E.R.D., R.B.S.), University of Rochester Medical Center, NY; Department of Brain and Psychological Sciences (T.L.M.), Boston University, MA; Department of Neurology (P.A., B.V., M.P.M., K.B., D.K., E.F.A., R.G.H., E.R.D., R.B.S.), University of Rochester Medical Center, NY; 23andMe, Inc. (P.C., H.M.R., D.C., E.C.), Sunnyvale, CA; Department of Neurology (K.A.), Westchester Medical Center, Poughkeepsie, NY; USA Department of Biostatistics and Computational Biology (M.P.M.), University of Rochester Medical Center, NY; Department of Neurology (R.N.A.), Columbia University, New York; Eli Lilly and Company (K.B.), Indianapolis, IN; Weill Institute for Neurosciences (C.T.), University of California, San Francisco; Valley Oaks Health (R.W.-E.), Lafayette, IN; and Department of Neurology and Neurogenetics (E.F.A.), Kennedy Krieger Institute, Baltimore, MD.
Ruth B SchneiderCenter for Health + Technology (S.J.-R., T.L.M., P.A., J.S., M.P., S.S., R.W., A.S., M.P.M., D.K., E.F.A., R.G.H., E.R.D., R.B.S.), University of Rochester Medical Center, NY; Department of Brain and Psychological Sciences (T.L.M.), Boston University, MA; Department of Neurology (P.A., B.V., M.P.M., K.B., D.K., E.F.A., R.G.H., E.R.D., R.B.S.), University of Rochester Medical Center, NY; 23andMe, Inc. (P.C., H.M.R., D.C., E.C.), Sunnyvale, CA; Department of Neurology (K.A.), Westchester Medical Center, Poughkeepsie, NY; USA Department of Biostatistics and Computational Biology (M.P.M.), University of Rochester Medical Center, NY; Department of Neurology (R.N.A.), Columbia University, New York; Eli Lilly and Company (K.B.), Indianapolis, IN; Weill Institute for Neurosciences (C.T.), University of California, San Francisco; Valley Oaks Health (R.W.-E.), Lafayette, IN; and Department of Neurology and Neurogenetics (E.F.A.), Kennedy Krieger Institute, Baltimore, MD.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background and Objectives: To recruit and characterize a national cohort of individuals who have a genetic variant ( Methods: In partnership with 23andMe, Inc., a personal genetics company, Results: Over 15 months, we enrolled 277 Discussion: An entirely remote national cohort of
Identifiers
What Socratic holds
Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390
Registered trials
None linked
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.